Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial

Author:

Tweed Conor D,Dawson Rodney,Burger Divan A,Conradie Almari,Crook Angela M,Mendel Carl M,Conradie Francesca,Diacon Andreas H,Ntinginya Nyanda E,Everitt Daniel E,Haraka Frederick,Li Mengchun,van Niekerk Christo H,Okwera Alphonse,Rassool Mohammed S,Reither Klaus,Sebe Modulakgotla A,Staples Suzanne,Variava Ebrahim,Spigelman Melvin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference29 articles.

1. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946–1986, with relevant subsequent publications;Fox;Int J Tuberc Lung Dis,1999

2. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era;Floyd;Lancet Respir Med,2018

3. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment;Banda;Int J Tuberc Lung Dis,2000

4. ‘Smear-negative’ pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence;Hargreaves;Int J Tuberc Lung Dis,2001

5. Factors that complicate the treatment of tuberculosis in HIV-infected patients;Dworkin;J Acquir Immune Defic Syndr,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3